Filing Flows › Comparisons › FOXO vs BIAF
Foxo Technologies vs bioAffinity Technologies: FOXO and BIAF compared
Foxo Technologies is the larger company: $4.7M of revenue in its latest quarter (Q2 2026) against $1.1M for bioAffinity Technologies (Q3 2026). Foxo Technologies is growing faster (-10% against -26% a year earlier). Foxo Technologies is more profitable, with an operating margin of 185.5% against -328.0%.
Where the money goes: FOXO and BIAF
Foxo Technologies (FOXO) · Q2 2026
Foxo Technologies, Q2 2026: revenue $4.7M (-10% year over year), operating margin 185.5%, net earnings $8.1M, operating cash flow $299K. The chart follows the revenue to costs, profit and cash.
bioAffinity Technologies (BIAF) · Q3 2026
bioAffinity Technologies, Q3 2026: revenue $1.1M (-26% year over year), operating margin -328.0%, net loss $5.3M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
| Foxo Technologies (FOXO) | bioAffinity Technologies (BIAF) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $4.7M | $1.1M |
| Revenue growth, Y/Y | -10% | -26% |
| Operating margin | 185.5% | -328.0% |
| Net earnings | $8.1M | −$5.3M |
| Net margin | 172.6% | -493.1% |
| Operating cash flow | $299K | −$3.9M |
| Free cash flow | $293K | — |
Where the revenue comes from
Foxo Technologies
- Health Cares: $4.5M (95%)
- Life Science Services: $238K (5%)
- Labs: $6K (0%)
bioAffinity Technologies
- Health Care, Patient Service: $863K (81%)
- Histology Service Fees: $190K (18%)
- Medical Director Fees: $17K (2%)
Questions
Which is bigger, Foxo Technologies or bioAffinity Technologies?
Foxo Technologies is the larger company: $4.7M of revenue in its latest quarter (Q2 2026) against $1.1M for bioAffinity Technologies (Q3 2026).
Is Foxo Technologies or bioAffinity Technologies growing faster?
Foxo Technologies is growing faster (-10% against -26% a year earlier).
Which is more profitable, Foxo Technologies or bioAffinity Technologies?
Foxo Technologies is more profitable, with an operating margin of 185.5% against -328.0%.
More: Foxo Technologies earnings · how Foxo Technologies makes money · bioAffinity Technologies earnings · how bioAffinity Technologies makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.